Mylan's Bresch on New FDA Rules, Company Outlook

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Oct. 27 (Bloomberg) -- Heather Bresch, president of Mylan Inc., discusses drug industry regulation and the outlook for the company's sales. Generic-drug makers such as Mylan will have to meet tighter standards to prove their blood-thinners and anti-seizure treatments work as well brand-name products, the U.S. Food and Drug Administration said earlier this week. Bresch, who will assume the chief executive officer post on Jan. 1, speaks on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change